By Shubham Batra and Shashwat Chauhan (Reuters) -European shares slipped on Friday after a rally in the previous session ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Friday, shares of Novo Nordisk A/S (NVO) are sliding following the announcement of safety results of phase 2a clinical trial of ...

Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...

European shares fell on Friday following a U.S. Federal Reserve interest rate cut. Drugmaker Novo Nordisk's obesity pill data ...

The European Medicines Agency backed the use of Novo Nordisk's NOVOb.CO popular drug Wegovy to help ease heart failure in ...

The agency said it filed a complaint in its administrative court alleging that CVS’s Caremark, Cigna’s Express Scripts and ...

UnitedHealth did not immediately respond to a request for comment. The FTC said it was also troubled by the role played by drug manufacturers such as Eli Lilly, Novo Nordisk, and Sanofi in the price ...

The Bank of England could cut interest rates to 2.75pc next year, analysts have suggested, amid growing confidence that the ...

Miplyffa (arimoclomol), an oral medication for Neimann-Pick disease, type C (NPC). Miplyffa, in combination with Johnson & ...